COLLEGIUM PHARMACEUTICAL INC. - COMMON STOCK

Collegium to Participate in Upcoming Investor Conferences

12 نوفمبر 2024 07:00:01 بحسب Nasdaq GlobeNewswire

Collegium Reports Record Third Quarter 2024 Financial Results

07 نوفمبر 2024 15:02:00 بحسب Nasdaq GlobeNewswire

Collegium Appoints Vikram Karnani as Chief Executive Officer

07 نوفمبر 2024 15:01:00 بحسب Nasdaq GlobeNewswire

Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024

24 أكتوبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: COLLEGIUM PHARMACEUTICAL INC. - COMMON STOCK

07 أكتوبر 2024 08:45:26 بحسب NetDania Notify

NetDania - New 12 months High: COLLEGIUM PHARMACEUTICAL INC. - COMMON STOCK

04 أكتوبر 2024 09:14:59 بحسب NetDania Notify

Collegium Completes Acquisition of Ironshore Therapeutics

04 سبتمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference

30 أغسطس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024

28 أغسطس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Collegium Reports Second Quarter 2024 Financial Results

08 أغسطس 2024 15:01:00 بحسب Nasdaq GlobeNewswire

Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology

29 يوليو 2024 05:00:00 بحسب Nasdaq GlobeNewswire

Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024

25 يوليو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise

13 يونيو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Collegium to Participate in Jefferies Global Healthcare Conference

29 مايو 2024 07:00:01 بحسب Nasdaq GlobeNewswire

Collegium Announces $35 Million Accelerated Share Repurchase Program

13 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Collegium Reports First Quarter 2024 Financial Results

09 مايو 2024 15:02:00 بحسب Nasdaq GlobeNewswire

Collegium Announces CEO Transition

09 مايو 2024 15:01:00 بحسب Nasdaq GlobeNewswire

Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER

29 أبريل 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

25 أبريل 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026

11 أبريل 2024 07:00:00 بحسب Nasdaq GlobeNewswire